Stockscreener 앱 받기
2.10
1.45%
0.03
시간 외 거래:
2.10
전일 마감가:
$2.07
열려 있는:
$2.07
하루 거래량:
747.70K
Relative Volume:
0.69
시가총액:
$227.50M
수익:
$27.08M
순이익/손실:
$-37.00M
주가수익비율:
-4.0385
EPS:
-0.52
순현금흐름:
$-18.46M
1주 성능:
+8.81%
1개월 성능:
+35.48%
6개월 성능:
+13.51%
1년 성능:
+77.97%
1일 변동 폭
$2.07
$2.15
1주일 범위
$1.93
$2.15
52주 변동 폭
$1.05
$5.17
Aclaris Therapeutics Inc Stock (ACRS) Company Profile
명칭
Aclaris Therapeutics Inc
전화
484-324-7933
주소
701 LEE ROAD, WAYNE, PA
ACRS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACRS
Aclaris Therapeutics Inc
|
2.10 | 224.25M | 27.08M | -37.00M | -18.46M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aclaris Therapeutics Inc Stock (ACRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Piper Sandler | Overweight |
| 2025-05-28 | 개시 | Wedbush | Outperform |
| 2025-03-18 | 재개 | Cantor Fitzgerald | Overweight |
| 2024-12-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-11-20 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-19 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-11-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-19 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-18 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-01-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-10-03 | 개시 | Evercore ISI | Outperform |
| 2022-12-14 | 개시 | Stifel | Buy |
| 2022-12-01 | 개시 | Goldman | Buy |
| 2022-10-06 | 개시 | BTIG Research | Buy |
| 2021-07-23 | 재개 | Jefferies | Buy |
| 2021-06-15 | 개시 | Piper Sandler | Overweight |
| 2021-04-21 | 개시 | H.C. Wainwright | Buy |
| 2019-10-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-09-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-27 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-05-06 | 개시 | SVB Leerink | Outperform |
| 2018-03-28 | 재개 | Leerink Partners | Outperform |
| 2018-02-09 | 개시 | Guggenheim | Buy |
| 2017-06-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2016-11-29 | 개시 | Leerink Partners | Outperform |
| 2016-09-30 | 개시 | JMP Securities | Mkt Outperform |
| 2016-06-10 | 개시 | Guggenheim | Buy |
| 2015-11-02 | 개시 | Citigroup | Buy |
| 2015-11-02 | 개시 | Jefferies | Buy |
모두보기
Aclaris Therapeutics Inc 주식(ACRS)의 최신 뉴스
What’s the recovery path for long term holders of Aclaris Therapeutics Inc.Quarterly Earnings Report & High Conviction Buy Zone Alerts - Newser
Will Aclaris Therapeutics Inc. benefit from rising consumer demandJuly 2025 Recap & Fast Moving Market Watchlists - خودرو بانک
Will Aclaris Therapeutics Inc. outperform the market in YEARMarket Activity Recap & Short-Term Swing Trade Alerts - خودرو بانک
Aclaris Therapeutics to Present at Two Investor Conferences in September - MSN
Is Aclaris Therapeutics Inc.’s ROE strong enough2025 Short Interest & Entry and Exit Point Strategies - خودرو بانک
Is Aclaris Therapeutics Inc. likely to announce a buybackQuarterly Performance Summary & Weekly Top Stock Performers List - خودرو بانک
Will Aclaris Therapeutics Inc. face regulatory challenges2025 Short Interest & Weekly Breakout Stock Alerts - خودرو بانک
Can technical indicators confirm Aclaris Therapeutics Inc.’s reversalBear Alert & Low Risk High Win Rate Stock Picks - Newser
Aclaris Therapeutics Inc. recovery potential after sell off2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Visual analytics tools that track Aclaris Therapeutics Inc. performanceFed Meeting & Real-Time Sentiment Analysis - Newser
Aclaris Therapeutics Inc. stock outlook for YEARWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Can Aclaris Therapeutics Inc. continue delivering strong returnsJuly 2025 Spike Watch & Long-Term Growth Plans - خودرو بانک
Aclaris Therapeutics Inc. stock momentum explainedJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - Newser
How sentiment analysis helps forecast Aclaris Therapeutics Inc.Market Movement Recap & Technical Confirmation Alerts - Newser
Can Aclaris Therapeutics Inc. recover in the next quarterMarket Performance Summary & AI Driven Price Forecasts - Newser
Market reaction to Aclaris Therapeutics Inc.’s recent news2025 Bull vs Bear & Smart Money Movement Tracker - Newser
Will Aclaris Therapeutics Inc. continue its uptrendPortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
What’s the MACD signal for Aclaris Therapeutics Inc.2025 Valuation Update & Daily Profit Maximizing Trade Tips - خودرو بانک
How to escape a deep drawdown in Aclaris Therapeutics Inc.2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Is Aclaris Therapeutics Inc. stock ready for a breakoutGap Up & Free Technical Confirmation Trade Alerts - Newser
Aclaris at Cantor Global Healthcare: Strategic Pipeline Insights - Investing.com
Forecasting Aclaris Therapeutics Inc. price range with options dataTrade Entry Report & Reliable Price Action Trade Plans - Newser
Using data tools to time your Aclaris Therapeutics Inc. exitJuly 2025 Catalysts & Weekly Setup with ROI Potential - Newser
Volatility clustering patterns for Aclaris Therapeutics Inc.2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Real time pattern detection on Aclaris Therapeutics Inc. stock2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
Long term hold vs stop loss in Aclaris Therapeutics Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
Aclaris Therapeutics Inc. stock trendline breakdown2025 Winners & Losers & Verified Technical Signals - Newser
Earnings visualization tools for Aclaris Therapeutics Inc.2025 Institutional Moves & Weekly High Potential Alerts - Newser
Is Aclaris Therapeutics Inc. a speculative investmentStop Loss & Weekly High Conviction Trade Ideas - خودرو بانک
What’s the beta of Aclaris Therapeutics Inc. stockPortfolio Update Report & Verified Short-Term Plans - خودرو بانک
Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific Officer - MSN
Developing predictive dashboards with Aclaris Therapeutics Inc. dataJuly 2025 Levels & Real-Time Buy Signal Alerts - Newser
Aclaris Therapeutics Inc. stock daily chart insightsGold Moves & High Yield Equity Trading Tips - Newser
Is Aclaris Therapeutics Inc. stock a falling knife or bargain buyJuly 2025 Volume & Expert Curated Trade Setup Alerts - خودرو بانک
Aclaris Therapeutics Inc. Volume Confirms Breakout — Analysts Bullish2025 Retail Activity & Fast Gaining Stock Strategy Reports - beatles.ru
Aclaris Therapeutics Inc (ACRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aclaris Therapeutics Inc 주식 (ACRS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mehra Anand | Director |
Nov 19 '24 |
Buy |
2.25 |
666,666 |
1,499,998 |
710,030 |
1.40%
자본화:
|
볼륨(24시간):